Objective:

To examine the role of platelet-derived DKK1 in modulating immune responses during Leishmania major infection and its implications for disease management in leishmaniasis and other infectious diseases.

Key Findings:

• Leishmania major infection promotes platelet activation and DKK1 release, which is significant for understanding immune modulation.
• Platelet-derived DKK1 enhances leukocyte-platelet aggregation and recruits immune cells to inflammatory sites, indicating its role in inflammation.
• DKK1 influences dendritic cell polarization, favoring Th2 and regulatory immune responses, which may affect treatment outcomes.
• Sustained DKK1 signaling may diminish protective Th1-associated responses, highlighting a potential therapeutic target.

Interpretation:

Platelet-derived DKK1 functions as an early regulator of both innate and adaptive immune responses during Leishmania infection, suggesting that targeting DKK1 could influence treatment strategies for other infectious diseases.

Limitations:

• The review primarily focuses on findings from mouse models, which may not fully translate to human conditions; further studies should include human data.
• Further studies are needed to clarify the translational relevance of DKK1 across various infectious diseases, particularly in clinical settings.

Conclusion:

Platelet-derived DKK1 is highlighted as a potential immunomodulatory target in the context of infectious diseases, with implications for future therapeutic strategies.